Research, Development, And Testing Services - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Research, industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Research, Development, And Testing Services - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Research, Development, And Testing Services
Corporate Insider Buy Sell Ratio (Insider Count) - Research, Development, And Testing Services
Research, Development, And Testing Services - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2025-10-17 BNBX / BNB Plus Corp. 4 SHAMASH YACOV A A - Award D 22,511
2025-10-17 BNBX / BNB Plus Corp. 4 Shorrock Clay A - Award D 18,691
2025-10-17 BNBX / BNB Plus Corp. 4 Jantzen Beth A - Award D 18,691
2025-10-17 BNBX / BNB Plus Corp. 4 Ceccoli Joseph D. A - Award D 22,511
2025-10-17 BNBX / BNB Plus Corp. 4 Ferguson Elizabeth M. A - Award D 22,511
2025-10-16 NEO / NeoGenomics, Inc. 4 Olivo Alicia C S - Sale D 10 -4,918
2025-10-15 INCY / Incyte Corporation 4 Denton Sheila A. S - Sale D 85.13 -277
2025-10-15 ONMD / OneMedNet Corporation 4 Casaburi Eric P - Purchase D 3.05 10,000
2025-10-15 INCY / Incyte Corporation 4 Denton Sheila A. M - Exercise D 64.25 277
2025-10-14 ABSI / Absci Corporation 4 McClain Sean F - Taxes D 3.68 -23,293
2025-10-14 ABSI / Absci Corporation 4 Jonasson Zachariah F - Taxes D 3.68 -387
2025-10-14 ABSI / Absci Corporation 4 Bedrick Todd F - Taxes D 3.68 -21,950
2025-10-14 ABSI / Absci Corporation 4 Busch Andreas F - Taxes D 3.68 -3,092
2025-10-03 INCY / Incyte Corporation 4 Denton Sheila A. S - Sale D 85.54 -3,501
2025-10-02 INCY / Incyte Corporation 4 Denton Sheila A. S - Sale D 87.65 -599
2025-10-02 INCY / Incyte Corporation 4 Denton Sheila A. M - Exercise D 58.06 599
2025-10-02 INCY / Incyte Corporation 4 Denton Sheila A. F - Taxes D 86.28 -3,130
2025-10-01 NOTV / Inotiv, Inc. 4 Neff R Matthew S - Sale D 1.4289 -2,000
2025-10-01 INCY / Incyte Corporation 4 Heeson Lee F - Taxes D 86.70 -463
2025-10-01 INCY / Incyte Corporation 4 Mayes Patrick A F - Taxes D 86.70 -1,569
2025-09-30 MEDP / Medpace Holdings, Inc. 4 Carley Brian T M - Exercise D 62
2025-09-30 MEDP / Medpace Holdings, Inc. 4 McCarthy Cornelius P. III M - Exercise D 49
2025-09-30 MEDP / Medpace Holdings, Inc. 4 Kraft Robert O. M - Exercise D 57
2025-09-30 INCY / Incyte Corporation 4 Clancy Paul J A - Award D 84.81 285
2025-09-30 INCY / Incyte Corporation 4 BAKER BROS. ADVISORS LP See Footnotes A - Award I 388
2025-09-30 INCY / Incyte Corporation 4 HARRIGAN EDMUND A - Award D 84.81 289
2025-09-30 INCY / Incyte Corporation 4 BAKER BROS. ADVISORS LP See Footnotes A - Award I 388
2025-09-29 NRC / NRC Health 4 HARRISON SHANE R A - Award D 172,000
2025-09-26 MEDP / Medpace Holdings, Inc. 4 BURWIG SUSAN E M - Exercise D 107.93 10,000
2025-09-25 ONMD / OneMedNet Corporation 4 Yu Jeffrey P - Purchase D 1.03 1,250
2025-09-24 ONMD / OneMedNet Corporation 4 Yu Jeffrey P - Purchase D 1.02 17,200
2025-09-24 ONMD / OneMedNet Corporation 4 Kosasa Thomas P - Purchase D 0.9331 6,000
2025-09-23 ONMD / OneMedNet Corporation 4 Yu Jeffrey P - Purchase D 0.93 5,700
2025-09-22 ONMD / OneMedNet Corporation 4 Yu Jeffrey P - Purchase D 0.95 400
2025-09-22 ABSI / Absci Corporation 4 Pangalos Menelas N P - Purchase D 2.66 95,785
2025-09-22 ABSI / Absci Corporation 4 Bedrick Todd P - Purchase D 2.70 10,000
2025-09-22 INCY / Incyte Corporation 4 Gardner David H A - Award D 9,429
2025-09-19 ONMD / OneMedNet Corporation 4 Yu Jeffrey P - Purchase D 0.89 1,250
2025-09-18 ONMD / OneMedNet Corporation 4 Yu Jeffrey P - Purchase D 0.91 700
2025-09-16 INCY / Incyte Corporation 4 Denton Sheila A. S - Sale D 83.15 -278
2025-09-16 INCY / Incyte Corporation 4 Denton Sheila A. M - Exercise D 64.25 278
2025-09-05 ONMD / OneMedNet Corporation 4 Yu Jeffrey P - Purchase D 0.86 2,100
2025-09-04 ONMD / OneMedNet Corporation 4 Yu Jeffrey P - Purchase D 0.87 11,810
2025-09-03 MEDP / Medpace Holdings, Inc. 4 BURWIG SUSAN E S - Sale D 480 -10,000
2025-09-03 ONMD / OneMedNet Corporation 4 Yu Jeffrey P - Purchase D 0.81 11,670
2025-09-02 MEDP / Medpace Holdings, Inc. 4 Troendle August J. S - Sale D 475.11 -1,197
2025-09-02 INCY / Incyte Corporation 4 Denton Sheila A. S - Sale D 84.97 -598
2025-09-02 NOTV / Inotiv, Inc. 4 Neff R Matthew S - Sale D 1.6688 -2,000
2025-09-02 ONMD / OneMedNet Corporation 4 Yu Jeffrey P - Purchase D 0.85 24,319
2025-09-02 INCY / Incyte Corporation 4 Denton Sheila A. M - Exercise D 58.06 598
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)